Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. The Super-Enhancer-Derived alncRNA-EC7/Bloodlinc Potentiates Red Blood Cell Development in  trans

The Super-Enhancer-Derived alncRNA-EC7/Bloodlinc Potentiates Red Blood Cell Development in  trans

Thumbnail Image
Download
Name

1-s2.0-S2211124717307568-main.pdf

Size

2.57 MB

Format

Adobe PDF

Checksum (MD5)

ff5acdbb2e34f774361bc52c46b39812

Download all files submitted through automated deposit
sword-2018-01-19.original.zip (1.68 MB)
Author(s)
Knoll, Marko
•
Alvarez, Juan Rene
•
Gromatzky, Austin A.
•
Lodish, Harvey F
Date Issued
June 2017
Journal
Cell Reports
Publisher
Elsevier
Citation
Alvarez-Dominguez, Juan R. et al. “The Super-Enhancer-Derived alncRNA-EC7/Bloodlinc Potentiates Red Blood Cell Development in  Trans.” Cell Reports 19, 12 (June 2017): 2503–2514 © 2017 The Author(s)
Version
Final published version
Abstract
Enhancer-derived RNAs are thought to act locally by contributing to their parent enhancer function. Whether large domains of clustered enhancers (super-enhancers) also produce cis-acting RNAs, however, remains unclear. Unlike typical enhancers, super-enhancers form large spans of robustly transcribed chromatin, amassing capped and polyadenylated RNAs that are sufficiently abundant to sustain trans functions. Here, we show that one such RNA, alncRNA-EC7/Bloodlinc, is transcribed from a super-enhancer of the erythroid membrane transporter SLC4A1/BAND3 but diffuses beyond this site. Bloodlinc localizes to trans-chromosomal loci encoding critical regulators and effectors of terminal erythropoiesis and directly binds chromatin-organizing and transcription factors, including the chromatin attachment factor HNRNPU. Inhibiting Bloodlinc or Hnrnpu compromises the terminal erythropoiesis gene program, blocking red cell production, whereas expressing Bloodlinc ectopically stimulates this program and can promote erythroblast proliferation and enucleation in the absence of differentiation stimuli. Thus, Bloodlinc is a trans-acting super-enhancer RNA that potentiates red blood cell development. Keywords enhancer RNA; super-enhancer; long non-coding RNA; erythropoiesis; red blood cell
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Attribution-NonCommercial-NoDerivatives 4.0 International
https://creativecommons.org/licenses/by-nc-nd/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/113274
DOI of Published Version
https://doi.org/10.1016/J.CELREP.2017.05.082
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.